Summit Therapeutics (SMMT) Tax Provisions (2019 - 2020)
Summit Therapeutics (SMMT) reported Tax Provisions of -$21000.0 for Q4 2020, down 142.86% on a YoY basis from $49000.0 in Q1 2020, and up 62.5% quarter-over-quarter from -$56000.0 in Q3 2020.
Summit Therapeutics (SMMT) Tax Provisions (2019 - 2020) Analysis & Trends
Summit Therapeutics has reported Tax Provisions for 2 years, with the latest figure at -$21000.0 in Q4 2020.
- For the quarter ending Q4 2020, Tax Provisions fell 142.86% year-over-year to -$21000.0; the trailing twelve-month figure through Sep 2021 stood at -$21000.0 (up 85.31% YoY), and the FY2020 full-year result was -$213000.0, down 691.67% from the prior year.
- Tax Provisions for Q4 2020 stood at -$21000.0, up from -$56000.0 in the prior quarter.
- The five-year high for Tax Provisions was $111000.0 in Q3 2019, with the low at -$191000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Summit Therapeutics | 10.09 Bn | 9.99 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -21,000.00 |
| Sep 30, 2020 | -56,000.00 |
| Jun 30, 2020 | -191,000.00 |
| Mar 31, 2020 | 55,000.00 |
| Dec 31, 2019 | 49,000.00 |
| Sep 30, 2019 | 111,000.00 |